Search clinical trials for: Hetrombopag Olamine

Total 5044 results

University of Malaya

Completed

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome

Schizophrenia

Malaysia
Pfizer

Completed

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Ukraine
Louisiana State University Health Sciences Center...
SAM Technology & The San Francisco Brain Research Institute

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

Schizophrenia | Schizoaffective Disorder

United States
Northwell Health
Bristol-Myers Squibb

Terminated

Aripiprazole Treatment of the Prodrome

Prodromal Schizophrenia | Prodromal Psychosis

United States
State University of New York - Upstate Medical...
Bristol-Myers Squibb

Completed

Aripiprazole as Augmentation for TRD

Depression

United States
Genovate Biotechnology Co., Ltd.,

Unknown

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Dyslipidemia | Weight Gain | Hyperprolactinemia
Otsuka Canada Pharmaceutical Inc.
Lundbeck Canada Inc.

Recruiting

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) (INITIATE)

Schizophrenia | Schizo Affective Disorder | Bipolar I Disorder

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Schizophrenia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Schizophrenia

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up (PAFIP3_nc3Y)

Psychotic Disorders | Schizophrenia | Psychosis

Spain
Alkermes, Inc.

Completed

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Schizophrenia

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Drinking and Craving

Alcohol Dependence

United States
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder

Bipolar Disorder

United States
Indiana University School of Medicine

Completed

A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

Fragile X Syndrome

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Amphetamine-Related Disorders

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

Schizophrenia
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S; Otsuka America Pharmaceutical

Completed

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Schizophrenia

United States, Croatia, Latvia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Tic Disorder | Tourette's Disorder

United States, Germany, Spain, Mexico, Romania, Canada, Hungary, Italy, Sweden
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) in Children With Symptoms of Mania

Bipolar Disorder

United States
Anne Katrine Pagsberg
Albert Einstein College of Medicine; The Research Council for Health and Disease... and other collaborators

Unknown

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA)

Psychosis

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Completed

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Schizophrenia

United States
Yoo-Sook Joung
Korea Otsuka International Asia Arab

Unknown

Study to Evaluate the Efficacy and Safety of Aripiprazole

Autism

Korea, Republic of, Philippines, Thailand
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Mood Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Dementia | Alzheimer's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients

Schizophrenia

Turkey, Austria, Germany, South Africa, Sweden, Finland, Czech Republic, Poland, France, Hungary, United Kingdom, Switzerland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Oral Aripiprazole Open-Label Rollover Study

Schizophrenia

Russian Federation, Argentina, Croatia, India, Serbia, Ukraine
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder | Chronic Motor or Vocal Tic Disorder

Korea, Republic of
University of Sao Paulo

Unknown

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients (ARIQUELI)

Bipolar I Disorder

Brazil
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression (Abilify)

Psychotic Depression

United States
Louisiana State University Health Sciences Center...
Bristol-Myers Squibb

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Schizophrenia | Schizoaffective Disorder

United States
Lindner Center of HOPE
University of Cincinnati

Completed

A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression

Bipolar Depression

United States
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Alzheimer's Disease

Sweden
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Unknown

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Dyskinesia, Drug-Induced

Taiwan
Taiwan Otsuka Pharm. Co., Ltd

Completed

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Taiwan
Federal University of São Paulo

Completed

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (AripipPTSD)

Posttraumatic Stress Disorder
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Health

China
Duke University
Otsuka America Pharmaceutical

Terminated

A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD

Post Traumatic Stress Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Major Depressive Disorder

United States

Search clinical trials for: Hetrombopag Olamine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations